Proteome Sciences plc (AIM:PRM)

London flag London · Delayed Price · Currency is GBP · Price in GBX
3.040
-0.200 (-6.17%)
Jul 25, 2025, 4:35 PM GMT+1
-6.17%
Market Cap8.97M
Revenue (ttm)4.89M
Net Income (ttm)-3.41M
Shares Out295.18M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14,580
Average Volume75,410
Open3.040
Previous Close3.040
Day's Range3.040 - 3.040
52-Week Range2.220 - 5.400
Beta-0.02
RSI46.50
Earnings DateAug 4, 2025

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling p... [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 1993
Employees 36
Stock Exchange London Stock Exchange AIM
Ticker Symbol PRM
Full Company Profile

Financial Performance

In 2024, Proteome Sciences's revenue was 4.89 million, a decrease of -2.80% compared to the previous year's 5.03 million. Losses were -3.41 million, 39.4% more than in 2023.

Financial Statements

News

AIM Market Roundup: Seascape Energy, Earnz, Directa Plus

Seascape Energy, Earnz, Directa Plus, RC Fornax and Proteome Sciences are today's biggest movers on London's AIM market

5 weeks ago - The Armchair Trader

AIM Market Roundup: Proteome Sciences, UKRProduct, Staffline

Proteome Sciences, UKRProduct, Staffline, ZOO Digital, Active Energy are today's biggest risers and fallers on London's AIM market

5 months ago - The Armchair Trader